|
FUJIFILM Biotechnologies is proud to be an innovative CDMO partner, seamlessly guiding our customers though their journey of creating life-impacting medicines from initial process development stages through to full commercial supply. Catch up on our latest news and insights below.
|
|
|
New Quality Control Laboratory Opens in Denmark
|
|
FUJIFILM Biotechnologies celebrated the opening of a new quality control (QC) laboratory at its commercial-scale manufacturing site in Hillerød, Denmark. This expansion doubles the site’s QC footprint, enabling bioassay and virology operations to support growing customer demand.
Designed for flexibility, the lab supports about 100 quality professionals, and incorporates robotics and a global Laboratory Information Management System (LIMS). The lab
received DKMA approval in March and began operations earlier this month.
This investment enhances the Hillerød site’s readiness for continued expansion and increasing process complexity, reinforcing FUJIFILM Biotechnologies’ ability to deliver high-quality biologics manufacturing at scale for patients with severe diseases.
|
|
|
Late Stage / Commercial Manufacturing
|
|
From internal manufacturing site to a cornerstone of Fujifilm’s global CDMO strategy,
learn how Denmark delivers scale, speed, and reliability.
|
|
|
Explore how investments in technology, capacity, and sustainability drive more resilient and scalable commercialization strategies for our partners.
|
|
|
Hear from Christian Houborg, SVP and Site Head, on the capabilities behind Fujifilm’s large-scale manufacturing site in Denmark.
|
|
|
- Lars Petersen, President and CEO of FUJIFILM Biotechnologies, recently sat down with Investment Reports to discuss the new era of life sciences, including how AI and evolving policy dynamics are shaping innovation, investment and the future of global healthcare. Read the
full article →
- Through a partnership with Geronimo Power, Fujifilm recently announced that it is now powering 100% of its electricity usage in the US and Canada through renewable energy certificates. Read the full article →
- FUJIFILM Biotechnologies' Holly Springs, NC, USA site received ISPE's 2026 Facility of the Year (FOYA) Honorable Mention for its application of modular design, digital delivery, and strong safety practices in large-scale biologics manufacturing. Read the full article →
- Rasmus Pedersen, Head of kojoX at FUJIFILM Biotechnologies, contributed to a feature article in The Pharma Navigator and shared his perspective on how growing demand for niche products is shifting manufacturing variability, requiring increased flexibility to manage complexity and operational efficiency. Read the full article →
|
|
June 22-25, 2026 | San Diego, CA | Booth 3123
|
|
Join us at BIO to hear about our latest global expansions and technologies and connect with experts to discuss how we can help advance your program and secure your supply. Visit us at booth #3123 or schedule a meeting today.
Learn More →
|
|
|
FUJIFILM Biotechnologies invites you to meet our senior subject matter experts during our process development roadshow. We understand the pressures and challenges associated with accelerated development timelines and scalability, so we designed this session to help you bridge the gap between your vision and execution.
|
|
|
Boston/Cambridge | June 16, 2026 | Glass House
Register Now →
|
|
South San Francisco | June 18, 2026 | Foundry & Lux
Register Now →
|
|
FUJIFILM Biotechnologies
101 J Morris Commons Ln Ste 135
Morrisville, North Carolina 27560
|
|
|
|
|
